A PROSPECTIVE, RANDOMIZED, SINGLE-MASKED, CONTROLLED, PARALLEL GROUPS, MULTICENTER CLINICAL INVESTIGATION OF THE GLAUKOSĀ® TRABECULAR MICRO-BYPASS STENT MODEL GTS400 USING THE G2-M-IS INJECTOR SYSTEM IN CONJUNCTION WITH CATARACT SURGERY

Trial ID:
IRB-13-6098
Quang Nguyen
The purpose of this study is to evaluate the safety and efficacy of the Glaukos Trabecular Micro-Bypass Stent Model GTS400 using the G2-M-IS injector system in conjunction with cataract surgery, compared to cataract surgery only, in subjects with mild to moderate primary open-angle glaucoma.

Inclusion Criteria:

  • Mild to moderate open-angle glaucoma
  • Characteristics consistent with mild/moderate glaucoma
  • Use of one (1) to three (3) medications at time of screening exam

Exclusion Criteria:

  • Pigmentary or pseudoexfoliative glaucoma
  • Prior incisional glaucoma surgery

Contact Info:

  • Jeff Wells, PharmD, MBA
  • jwells@glaukos.com
  • 949-367-9600